SVRA Stock Price
Savara Inc.
$4.83
-$0.05(-1.02%)
37
Overall
50
Value
27
Tech
36
Quality
Market Cap
$1.00B
Volume
2.51M
52W Range
$3.34 - $7.01
Target Price
$10.94
SVRA stock price is $4.83 (-1.02% on the day), giving Savara Inc. a market cap of $1.00B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
SVRA Stock Overview
- Price
- $4.83
- Previous close
- $4.88
- Open
- $4.85
- Market cap
- $1.00B
- P/E ratio
- -8.4
- 52-week range
- $3.34 - $7.00
- 1-year price target
- $10.94
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 37
About Savara Inc.
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Langhorne, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SVRA | $4.83 | -1.0% | 2.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |